The insider transactions at Pyxis Oncology do not provide mu...
The insider transactions at Pyxis Oncology do not provide much encouragement. However, the fact that insiders own a significant portion of the company suggests a reasonable degree of alignment with other shareholders.
Insiders Who Sold Pyxis Oncology Made The Right Call As Market Cap Slides By US$50m
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment